By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on SpaceX's IPO, citing high valuation, heavy capex requirements, regulatory risks, and potential selling pressure post-lockup.
Risk: Massive capex and regulatory/spectrum risks delaying free cash flow and potential liquidity crunch post-lockup.
Opportunity: None identified.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Technology and growth stocks have led gains in the S&P 500 over the past few years. Investors have piled into players such as artificial intelligence (AI) chip leader Nvidia and electric vehicle giant Tesla, for example. Those stocks have climbed 400% and 70%, respectively, over the past three years.
Today, investors may continue to win with these market giants -- and they may turn to new opportunities, including tech and industrial giant SpaceX. This Elon Musk-owned company is on track to launch the biggest ever initial public offering as soon as June 12. It follows an IPO by AI chip company Cerebras Systems, and it precedes operations by AI labs Anthropic and OpenAI -- they both recently submitted confidential IPO filings to regulators.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
SpaceX has wowed the market with its IPO intentions -- aiming to reach a valuation of more than $1.7 trillion -- as well as its position in the growth markets of rocket launches, AI, and satellite internet connectivity.
Should you buy SpaceX on its first day of trading? Let's find out.
It's clear that SpaceX is an exciting company. Like Tesla, it's led by Elon Musk, who is known for his focus on innovation and for (excuse the pun) reaching for the stars. Musk, for example, at the helm of Tesla, aims to lead in autonomous vehicles, and at SpaceX, his goals range from installing data centers in space to creating a city on Mars. Some of Musk's goals may be attainable, but others may never become a reality. Still, a Musk-led company may be successful even if he doesn't reach every goal.
SpaceX today, through its three businesses, offers investors certain key elements. One of them is diversification -- this limits risk to a certain degree because if one particular area struggles, another may compensate. These businesses are also complementary, with gains in one benefiting the others. For example, progress on reusable rockets will make it cheaper and easier for SpaceX to pursue its various space-based projects, such as launching materials for its Starlink internet service.
And speaking of Starlink, this business is the company's revenue driver as it works to build up its other units. Last year, Starlink delivered $4.4 billion in income from operations.
All of that is positive, but it's important to note that SpaceX still comes with a fair amount of risk. The AI business requires significant investment, and that's weighing on overall earnings. Capital expenditures in that unit totaled $12 billion last year, and that pushed SpaceX to a loss. Meanwhile, the company's valuation is high. In fact, Morningstar says the company is worth $780 billion -- that's less than half of its private market valuation of $1.5 trillion.
Now, let's return to our question: Should you buy SpaceX on IPO day? It's important to note that SpaceX already has set a fixed price, at $135 a share, for its stock, but it's very likely that the stock won't open at that price. If it follows in the footsteps of Cerebras, it could open considerably higher. Cerebras priced at $185, opened at $350, and then gained 68% during that first day of trading.
Based on all of this -- the positive and negative points I've mentioned above -- I wouldn't rush to get in on SpaceX on IPO day. Though the company offers an exciting growth story, the current valuation is high, and it seems likely that in the weeks or months to come, investors may find a better entry point on the dip. By letting some time pass, investors will also have the opportunity to review additional earnings reports and consider the company's progress toward at least some of its goals -- and monitor the capital expenditure levels.
So, I wouldn't rush to get in on SpaceX right out of the gate and potentially pay a premium for the stock. Instead, I would wait to get in on this player at a later date -- with additional financial information available and at a better price.
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 926%* — a market-crushing outperformance compared to 203% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
**Stock Advisor returns as of June 11, 2026. *
Adria Cimino has positions in Tesla. The Motley Fool has positions in and recommends Nvidia and Tesla. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"SpaceX's IPO price implies a valuation far beyond current cash flow and profitability, making a cautious entry prudent rather than chasing hype."
SpaceX's IPO narrative hinges on moon-shot potential (Starlink, Mars plans) and Musk-brand halo, but the math behind a $1.7 trillion valuation is thin. The core, cash-generating engine—Starlink—still requires heavy capex and faces regulatory, competitive, and geopolitical risks; the AI/space cycle is volatile, and Morningstar's $780B figure underscores a wide valuation gap with private markets. Public markets will demand a credible, time-bound path to sustained profitability and free cash flow, not just aspirational milestones. The hype can push the first-day pop, but the longer-run risk is outsized if capex remains runaway and earnings disclosures lag.
Big bullish counter: Starlink revenue acceleration and strong defense/commercial space deals could drive a sharp re-rating, and the founder-led momentum may sustain a premium despite the cash burn.
"The article presents speculative, unverified IPO rumors as fact, ignoring the extreme capital intensity and regulatory risks inherent in SpaceX's current private business model."
This article is riddled with red flags, most notably the June 12th IPO date, which contradicts the reality that SpaceX remains a private entity with no official SEC filing for a public listing. A $1.7 trillion valuation would make it one of the world's most valuable companies, yet the piece conflates private funding rounds with public market pricing. Investors should be wary of the 'Musk premium' and the massive capital expenditure (CapEx) cycle required for Starlink and Starship. While Starlink’s $4.4 billion in revenue is impressive, the cash burn required to maintain orbital dominance is astronomical. Buying at an IPO premium without audited public filings is speculative gambling, not fundamental investing.
If SpaceX achieves a monopoly in low-Earth orbit satellite internet and successfully lowers launch costs via Starship, it could justify a premium valuation by effectively becoming the 'utility company' for the entire space economy.
"A $1.7T valuation on a company with $4.4B profitable revenue (Starlink) and $12B losses elsewhere implies 386x forward revenue multiple—unsustainable without decade-long hypergrowth that has never materialized in aerospace."
This article is promotional fluff masquerading as analysis. The $1.7T valuation claim is unverified—Morningstar's $780B estimate suggests 118% upside is already priced in before trading begins. The article conflates Elon Musk's innovation track record (Tesla, real revenue) with SpaceX's speculative ventures (Mars cities, space data centers). Starlink's $4.4B operating income is real, but the AI/satellite constellation businesses are capital sinks—$12B capex pushed the company to losses. IPO day euphoria (Cerebras +68% first day) typically precedes 6-12 month corrections. The fixed $135 price is irrelevant; what matters is post-IPO momentum and whether institutional lockup expiration creates selling pressure.
SpaceX's Starlink already has 10M+ subscribers with path to profitability, and reusable rocket economics genuinely reduce launch costs—if execution continues, the company could justify premium valuations that most IPO skeptics dismiss.
"SpaceX's $1.7T IPO valuation is more than double Morningstar's estimate, making first-day buying vulnerable to rapid re-rating once earnings reveal sustained losses."
The article rightly highlights the valuation gap—Morningstar's $780B versus the $1.7T IPO target—and $12B AI capex driving losses, but glosses over Starlink's regulatory and spectrum risks plus potential delays in reusable rocket scaling that could widen cash burn. Cerebras' 89% first-day pop is cited as precedent, yet that ignores SpaceX's much larger size and ongoing negative earnings. Investors should watch post-IPO filings for capex trends rather than chase the open at a premium to the $135 fixed price.
Musk-led names like Tesla have repeatedly sustained multiples well above analyst targets when narrative execution surprises to the upside, so any post-IPO dip could be shallow and short-lived if Starlink adds subscribers faster than modeled.
"Regulatory/spectrum delays could push capex and delay profitability, undermining near-term valuation despite subs growth."
Gemini's jab on June 12 IPO date misses the real gating item: spectrum/regulatory risk and delayed equipment licensing could push capex into 2025–26, delaying free cash flow. Even if Starlink hits 10M+ subs and Starship cost cuts, the time-to-profitability remains long, risking a broader multiple unwind if post-IPO lockups and fundraising pressure hits; the article may be too optimistic on timeline.
"The post-IPO lockup expiration for early private investors poses a greater threat to share price stability than current fundamental valuation gaps."
Claude, your focus on institutional lockups is the most critical technical risk here. If SpaceX goes public, the massive concentration of shares among early private investors and venture funds will create a supply-demand mismatch post-lockup that dwarfs the initial IPO float. While everyone is debating Starlink's subscriber growth, the real danger is a liquidity crunch when insiders exit into a retail-heavy, hype-driven market. This isn't just about valuation; it's about structural selling pressure.
"Lockup pressure matters less than earnings trajectory; narrative breaks on execution miss, not technical selling."
Gemini's lockup thesis is sharp, but it assumes retail demand sustains through the unlock. History shows founder-led IPOs (Tesla, Nvidia under Jensen) see insider selling absorbed by institutional rebalancing and fresh capital inflows. The real risk isn't lockup timing—it's if Q1 2025 capex guidance disappoints or Starlink churn accelerates. That's the catalyst that breaks the narrative, not share supply mechanics.
"Regulatory delays could turn capex disappointments into a lockup-driven selloff catalyst."
Claude underestimates how regulatory delays in spectrum allocation could directly trigger the capex guidance misses he flags. If Starlink's expansion stalls into 2025 due to licensing hurdles, the resulting cash burn extension would likely overwhelm any institutional absorption of lockup shares that Gemini highlighted. This creates a feedback loop where narrative cracks accelerate selling pressure beyond simple supply mechanics, especially if Q1 disclosures show prolonged losses.
The panel consensus is bearish on SpaceX's IPO, citing high valuation, heavy capex requirements, regulatory risks, and potential selling pressure post-lockup.
None identified.
Massive capex and regulatory/spectrum risks delaying free cash flow and potential liquidity crunch post-lockup.